1-20 of 36
Vivian A. Fonseca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women

Yilin Yoshida, Zhipeng Chen, Robin L. Baudier, Marie Krousel-Wood, Amanda H. Anderson, Vivian A. Fonseca, Franck Mauvais-Jarvis
Journal: Diabetes Care
Diabetes Care 2021;44(11):2564–2572
https://doi.org/10.2337/dc21-1107
Published: 02 September 2021
View article titled, Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women
Open the PDF for Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women in another window
Journal Articles

Replacement of Sedentary Behavior by Various Daily-Life Physical Activities and Structured Exercises: Genetic Risk and Incident Type 2 Diabetes

Xiang Li, Tao Zhou, Hao Ma, Zhaoxia Liang, Vivian A. Fonseca, Lu Qi
Journal: Diabetes Care
Diabetes Care 2021;44(10):2403–2410
https://doi.org/10.2337/dc21-0455
Published: 28 June 2021
View article titled, Replacement of Sedentary Behavior by Various Daily-Life Physical Activities and Structured Exercises: Genetic Risk and Incident Type 2 Diabetes
Open the PDF for Replacement of Sedentary Behavior by Various Daily-Life Physical Activities and Structured Exercises: Genetic Risk and Incident Type 2 Diabetes in another window
Journal Articles

Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study

Mengying Wang, Tao Zhou, Xiang Li, Hao Ma, Zhaoxia Liang, Vivian A. Fonseca, Yoriko Heianza, Lu Qi
Journal: Diabetes Care
Diabetes Care 2020;43(11):2776–2784
https://doi.org/10.2337/dc20-1109
Published: 26 August 2020
View article titled, Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study
Open the PDF for Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study in another window
Journal Articles

Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium–Glucose Transporter 2 Inhibitors

Hui Shao, Lizheng Shi, Vivian A. Fonseca
Journal: Diabetes Care
Diabetes Care 2020;43(7):1530–1536
https://doi.org/10.2337/dc20-0227
Published: 28 April 2020
View article titled, Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium–Glucose Transporter 2 Inhibitors
Open the PDF for Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium–Glucose Transporter 2 Inhibitors in another window
Journal Articles

Diabetes INSIDE: Improving Population HbA1c Testing and Targets in Primary Care With a Quality Initiative

Roy E. Furman, Timothy S. Harlan, Lesley LeBlanc, Elise C. Furman, Greg Liptak, Vivian A. Fonseca
Journal: Diabetes Care
Diabetes Care 2020;43(2):329–336
https://doi.org/10.2337/dc19-0454
Published: 03 December 2019
View article titled, Diabetes INSIDE: Improving Population HbA<sub>1c</sub> Testing and Targets in Primary Care With a Quality Initiative
Open the PDF for Diabetes INSIDE: Improving Population HbA<sub>1c</sub> Testing and Targets in Primary Care With a Quality Initiative in another window
Includes: Supplementary data
Journal Articles

Post-ACA Racial Disparity of Eye Examinations Among the U.S. Noninstitutionalized Population With Diabetes: 2014–2015

Alisha M. Monnette, M. Kristina Wharton, Yingnan Zhao, Vivian A. Fonseca, Lizheng Shi
Journal: Diabetes Care
Diabetes Care 2019;42(5):e70–e72
https://doi.org/10.2337/dc18-1991
Published: 12 March 2019
View article titled, Post-ACA Racial Disparity of Eye Examinations Among the U.S. Noninstitutionalized Population With Diabetes: 2014–2015
Open the PDF for Post-ACA Racial Disparity of Eye Examinations Among the U.S. Noninstitutionalized Population With Diabetes: 2014–2015 in another window
Journal Articles

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study

Jay S. Skyler, Vivian A. Fonseca, Karen R. Segal, Julio Rosenstock
Journal: Diabetes Care
Diabetes Care 2015;38(9):1742–1749
https://doi.org/10.2337/dc14-2830
Published: 07 July 2015
View article titled, Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
Open the PDF for Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study in another window
Includes: Supplementary data
Journal Articles

Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act

Harvey W. Kaufman, Zhen Chen, Vivian A. Fonseca, Michael J. McPhaul
Journal: Diabetes Care
Diabetes Care 2015;38(5):833–837
https://doi.org/10.2337/dc14-2334
Published: 23 March 2015
View article titled, Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act
Open the PDF for Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act in another window
Includes: Supplementary data
Journal Articles

Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database

M. Sue Kirkman, Megan T. Rowan-Martin, Rebecca Levin, Vivian A. Fonseca, Julie A. Schmittdiel, William H. Herman, Ronald E. Aubert
Journal: Diabetes Care
Diabetes Care 2015;38(4):604–609
https://doi.org/10.2337/dc14-2098
Published: 08 January 2015
View article titled, Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Open the PDF for Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database in another window
Journal Articles

Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

Julio Rosenstock, Vivian A. Fonseca, Jorge L. Gross, Robert E. Ratner, Bo Ahrén, Francis C.C. Chow, Fred Yang, Diane Miller, Susan L. Johnson, Murray W. Stewart, Lawrence A. Leiter
Journal: Diabetes Care
Diabetes Care 2014;37(8):2317–2325
https://doi.org/10.2337/dc14-0001
Published: 12 July 2014
View article titled, Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro
Open the PDF for Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro in another window
Includes: Supplementary data
Journal Articles

Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes

Lizheng Shi, PHD, Xin Ye, PHD, Mei Lu, MS, Eric Q. Wu, PHD, Hari Sharma, BS, Darren Thomason, BA, Vivian A. Fonseca, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3297–3304
https://doi.org/10.2337/dc13-0149
Published: 14 September 2013
View article titled, Clinical and Economic Benefits Associated With the Achievement of Both HbA<sub>1c</sub> and LDL Cholesterol Goals in Veterans With Type 2 Diabetes
Open the PDF for Clinical and Economic Benefits Associated With the Achievement of Both HbA<sub>1c</sub> and LDL Cholesterol Goals in Veterans With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China

Wenjing Zhao, MHA, Lizheng Shi, PHD, Vivian A. Fonseca, MD, Jiang He, PHD, Decheng Shao, MBBS, Jie Zhao, MBBS, Qingmei Chen, MHA, Aitian Yin, MBBS
Journal: Diabetes Care
Diabetes Care 2013;36(9):e159–e160
https://doi.org/10.2337/dc13-1007
Published: 13 August 2013
View article titled, Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China
Open the PDF for Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China in another window
Journal Articles

Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial

Guillermo E. Umpierrez, MD, Dawn Smiley, MD, Kathie Hermayer, MD, Amna Khan, MD, Darin E. Olson, MD, Christopher Newton, MD, Sol Jacobs, MD, Monica Rizzo, MD, Limin Peng, PHD, David Reyes, MD, Ingrid Pinzon, MD, Maria Eugenia Fereira, MD, Vicky Hunt, BA, Ashwini Gore, MD, Marcos T. Toyoshima, MD, Vivian A. Fonseca, MD
Journal: Diabetes Care
Diabetes Care 2013;36(8):2169–2174
https://doi.org/10.2337/dc12-1988
Published: 11 July 2013
View article titled, Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: <subtitle>Basal Plus Trial</subtitle>
Open the PDF for Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: <subtitle>Basal Plus Trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Vivian A. Fonseca, MD, Ricardo Alvarado-Ruiz, MD, Denis Raccah, MD, Gabor Boka, MD, Patrick Miossec, MD, John E. Gerich, MD, on behalf of the EFC6018 GetGoal-Mono Study Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(6):1225–1231
https://doi.org/10.2337/dc11-1935
Published: 11 May 2012
View article titled, Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: <subtitle>A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)</subtitle>
Open the PDF for Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: <subtitle>A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)</subtitle> in another window
Includes: Supplementary data
Journal Articles

The American Diabetes Association Diabetes Research Perspective

Vivian A. Fonseca, MD, M. Sue Kirkman, MD, Tamara Darsow, PHD, Robert E. Ratner, MD
Journal: Diabetes Care
Diabetes Care 2012;35(6):1380–1387
https://doi.org/10.2337/dc12-9001
Published: 11 May 2012
View article titled, The American Diabetes Association Diabetes Research Perspective
Open the PDF for The American Diabetes Association Diabetes Research Perspective in another window
Journal Articles

Iron and Diabetes Revisited

Sudhir V. Shah, MD, Vivian A. Fonseca, MD
Journal: Diabetes Care
Diabetes Care 2011;34(7):1676–1677
https://doi.org/10.2337/dc11-0700
Published: 17 June 2011
View article titled, Iron and Diabetes Revisited
Open the PDF for Iron and Diabetes Revisited in another window
Journal Articles

Finishing Strong

Vivian A. Fonseca, MD
Journal: Diabetes Care
Diabetes Care 2011;34(1):1
https://doi.org/10.2337/dc10-1990
Published: 01 January 2011
View article titled, Finishing Strong
Open the PDF for Finishing Strong in another window
Journal Articles

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Julio Rosenstock, MD, Salomon Banarer, MD, Vivian A. Fonseca, MD, Silvio E. Inzucchi, MD, William Sun, PHD, Wenqing Yao, PHD, Gregory Hollis, PHD, Robert Flores, BSN, Richard Levy, MD, William V. Williams, MD, Jonathan R. Seckl, MD, Reid Huber, PHD, for the INCB13739-202 Principal Investigators
Journal: Diabetes Care
Diabetes Care 2010;33(7):1516–1522
https://doi.org/10.2337/dc09-2315
Published: 22 April 2010
View article titled, The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Open the PDF for The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy in another window
Includes: Supplementary data
Journal Articles

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Jorge Calles-Escandón, MD, Laura C. Lovato, MS, Denise G. Simons-Morton, MD, PHD, David M. Kendall, MD, Rodica Pop-Busui, MD, Robert M. Cohen, MD, Denise E. Bonds, MD, Vivian A. Fonseca, MD, Faramarz Ismail-Beigi, MD, PHD, Mary Ann Banerji, MD, Alan Failor, MD, Bruce Hamilton, MD
Journal: Diabetes Care
Diabetes Care 2010;33(4):721–727
https://doi.org/10.2337/dc09-1471
Published: 26 January 2010
View article titled, Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: <subtitle>The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial</subtitle>
Open the PDF for Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: <subtitle>The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Bo Ahrén, MD, PHD, James E. Foley, PHD, Ele Ferrannini, MD, David R. Matthews, MD, Bernard Zinman, MD, Sylvie Dejager, MD, PHD, Vivian A. Fonseca, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2010;33(4):730–732
https://doi.org/10.2337/dc09-1867
Published: 12 January 2010
View article titled, Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
Open the PDF for Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy in another window